Virtu KCG Holdings’s Theriva Biologics TOVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q2
$34K Sell
7
-3
-30% -$14.6K ﹤0.01% 2651
2017
Q1
$54K Sell
10
-10
-50% -$54K ﹤0.01% 2809
2016
Q4
$133K Buy
20
+17
+567% +$113K ﹤0.01% 2779
2016
Q3
$50K Sell
3
-4
-57% -$66.7K ﹤0.01% 2768
2016
Q2
$106K Buy
+7
New +$106K ﹤0.01% 2511
2016
Q1
Sell
-18
Closed -$362K 3271
2015
Q4
$362K Buy
18
+13
+260% +$261K 0.01% 1542
2015
Q3
$107K Buy
5
+4
+400% +$85.6K ﹤0.01% 2343
2015
Q2
$34K Sell
1
-8
-89% -$272K ﹤0.01% 2623
2015
Q1
$176K Hold
9
﹤0.01% 1967
2014
Q4
$119K Buy
9
+4
+80% +$52.9K ﹤0.01% 2265
2014
Q3
$74K Buy
+5
New +$74K ﹤0.01% 2358